FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to formula (I) compound or its stereoisomer, or its pharmaceutically acceptable salt, where M stands for cation, and its application in prevention and treatment of bacterial infections.
EFFECT: obtaining compounds for treatment of bacterial infections.
15 cl, 6 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBACTERIAL AGENTS | 2015 |
|
RU2705375C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBACTERIAL AGENTS | 2014 |
|
RU2702361C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2578370C2 |
1,6-DIAZABICYCLO [3,2,1] OCTANE-7-ONA DERIVATIVES AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2013 |
|
RU2614418C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND THEIR APPLICATION FOR BACTERIAL INFECTIONS TREATMENT | 2012 |
|
RU2636147C1 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONА DERIVATIVES AND USING THEM IN TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2570423C2 |
ANTIBACTERIAL COMPOSITIONS | 2013 |
|
RU2646798C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2569059C2 |
COMPOSITIONS AND METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2676482C2 |
ANTIBACTERIAL COMPOSITIONS AND METHODS | 2017 |
|
RU2779346C2 |
Authors
Dates
2015-11-20—Published
2012-09-11—Filed